1
|
Retinal biomarkers and pharmacological targets for Hermansky-Pudlak syndrome 7. Sci Rep 2020; 10:3972. [PMID: 32132582 PMCID: PMC7055265 DOI: 10.1038/s41598-020-60931-5] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2019] [Accepted: 02/19/2020] [Indexed: 01/24/2023] Open
Abstract
Deletion of dystrobrevin binding protein 1 has been linked to Hermansky-Pudlak syndrome type 7 (HPS-7), a rare disease characterized by oculocutaneous albinism and retinal dysfunction. We studied dysbindin-1 null mutant mice (Dys−/−) to shed light on retinal neurodevelopment defects in HPS-7. We analyzed the expression of a focused set of miRNAs in retina of wild type (WT), Dys+/− and Dys−/− mice. We also investigated the retinal function of these mice through electroretinography (ERG). We found that miR-101-3p, miR-137, miR-186-5p, miR-326, miR-382-5p and miR-876-5p were up-regulated in Dys−/−mice retina. Dys−/− mice showed significant increased b-wave in ERG, compared to WT mice. Bioinformatic analysis highlighted that dysregulated miRNAs target synaptic plasticity and dopaminergic signaling pathways, affecting retinal functions of Dys−/− mice. Overall, the data indicate potential mechanisms in retinal neurodevelopment of Dys−/− mice, which may have translational significance in HSP-7 patients, both in terms of diagnostic/prognostic biomarkers and novel pharmacological targets.
Collapse
|
2
|
Flood MD, Moore-Dotson JM, Eggers ED. Dopamine D1 receptor activation contributes to light-adapted changes in retinal inhibition to rod bipolar cells. J Neurophysiol 2018; 120:867-879. [PMID: 29847232 PMCID: PMC6139461 DOI: 10.1152/jn.00855.2017] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2017] [Revised: 05/22/2018] [Accepted: 05/25/2018] [Indexed: 12/27/2022] Open
Abstract
Dopamine modulation of retinal signaling has been shown to be an important part of retinal adaptation to increased background light levels, but the role of dopamine modulation of retinal inhibition is not clear. We previously showed that light adaptation causes a large reduction in inhibition to rod bipolar cells, potentially to match the decrease in excitation after rod saturation. In this study, we determined how dopamine D1 receptors in the inner retina contribute to this modulation. We found that D1 receptor activation significantly decreased the magnitude of inhibitory light responses from rod bipolar cells, whereas D1 receptor blockade during light adaptation partially prevented this decline. To determine what mechanisms were involved in the modulation of inhibitory light responses, we measured the effect of D1 receptor activation on spontaneous currents and currents evoked from electrically stimulating amacrine cell inputs to rod bipolar cells. D1 receptor activation decreased the frequency of spontaneous inhibition with no change in event amplitudes, suggesting a presynaptic change in amacrine cell activity in agreement with previous reports that rod bipolar cells lack D1 receptors. Additionally, we found that D1 receptor activation reduced the amplitude of electrically evoked responses, showing that D1 receptors can modulate amacrine cells directly. Our results suggest that D1 receptor activation can replicate a large portion but not all of the effects of light adaptation, likely by modulating release from amacrine cells onto rod bipolar cells. NEW & NOTEWORTHY We demonstrated a new aspect of dopaminergic signaling that is involved in mediating light adaptation of retinal inhibition. This D1 receptor-dependent mechanism likely acts through receptors located directly on amacrine cells, in addition to its potential role in modulating the strength of serial inhibition between amacrine cells. Our results also suggest that another D2/D4 receptor-dependent or dopamine-independent mechanism must also be involved in light adaptation of inhibition to rod bipolar cells.
Collapse
Affiliation(s)
- Michael D Flood
- Departments of Physiology and Biomedical Engineering, University of Arizona , Tucson, Arizona
| | - Johnnie M Moore-Dotson
- Departments of Physiology and Biomedical Engineering, University of Arizona , Tucson, Arizona
| | - Erika D Eggers
- Departments of Physiology and Biomedical Engineering, University of Arizona , Tucson, Arizona
| |
Collapse
|
3
|
Liu X, Grove JCR, Hirano AA, Brecha NC, Barnes S. Dopamine D1 receptor modulation of calcium channel currents in horizontal cells of mouse retina. J Neurophysiol 2016; 116:686-97. [PMID: 27193322 DOI: 10.1152/jn.00990.2015] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2015] [Accepted: 05/12/2016] [Indexed: 12/22/2022] Open
Abstract
Horizontal cells form the first laterally interacting network of inhibitory interneurons in the retina. Dopamine released onto horizontal cells under photic and circadian control modulates horizontal cell function. Using isolated, identified horizontal cells from a connexin-57-iCre × ROSA26-tdTomato transgenic mouse line, we investigated dopaminergic modulation of calcium channel currents (ICa) with whole cell patch-clamp techniques. Dopamine (10 μM) blocked 27% of steady-state ICa, an action blunted to 9% in the presence of the L-type Ca channel blocker verapamil (50 μM). The dopamine type 1 receptor (D1R) agonist SKF38393 (20 μM) inhibited ICa by 24%. The D1R antagonist SCH23390 (20 μM) reduced dopamine and SKF38393 inhibition. Dopamine slowed ICa activation, blocking ICa by 38% early in a voltage step. Enhanced early inhibition of ICa was eliminated by applying voltage prepulses to +120 mV for 100 ms, increasing ICa by 31% and 11% for early and steady-state currents, respectively. Voltage-dependent facilitation of ICa and block of dopamine inhibition after preincubation with a Gβγ-blocking peptide suggested involvement of Gβγ proteins in the D1R-mediated modulation. When the G protein activator guanosine 5'-O-(3-thiotriphosphate) (GTPγS) was added intracellularly, ICa was smaller and showed the same slowed kinetics seen during D1R activation. With GTPγS in the pipette, additional block of ICa by dopamine was only 6%. Strong depolarizing voltage prepulses restored the GTPγS-reduced early ICa amplitude by 36% and steady-state ICa amplitude by 3%. These results suggest that dopaminergic inhibition of ICa via D1Rs is primarily mediated through the action of Gβγ proteins in horizontal cells.
Collapse
Affiliation(s)
- Xue Liu
- Biomaterials and Live Cell Imaging Institute, Chongqing University of Science and Technology, Chongqing, People's Republic of China; Department of Neurobiology and Jules Stein Eye Institute, David Geffen School of Medicine, University of California, Los Angeles, California
| | - James C R Grove
- Department of Neurobiology and Jules Stein Eye Institute, David Geffen School of Medicine, University of California, Los Angeles, California
| | - Arlene A Hirano
- Department of Neurobiology and Jules Stein Eye Institute, David Geffen School of Medicine, University of California, Los Angeles, California; Department of Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California; and
| | - Nicholas C Brecha
- Department of Neurobiology and Jules Stein Eye Institute, David Geffen School of Medicine, University of California, Los Angeles, California; Department of Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California; and
| | - Steven Barnes
- Department of Neurobiology and Jules Stein Eye Institute, David Geffen School of Medicine, University of California, Los Angeles, California; Department of Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California; and Department of Physiology and Biophysics and Department of Ophthalmology and Visual Sciences, Dalhousie University, Halifax, Nova Scotia, Canada
| |
Collapse
|
4
|
Popova E. Role of dopamine in distal retina. J Comp Physiol A Neuroethol Sens Neural Behav Physiol 2014; 200:333-58. [PMID: 24728309 DOI: 10.1007/s00359-014-0906-2] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2013] [Revised: 03/24/2014] [Accepted: 03/25/2014] [Indexed: 01/11/2023]
Abstract
Dopamine is the most abundant catecholamine in the vertebrate retina. Despite the description of retinal dopaminergic cells three decades ago, many aspects of their function in the retina remain unclear. There is no consensus among the authors about the stimulus conditions for dopamine release (darkness, steady or flickering light) as well as about its action upon the various types of retinal cells. Many contradictory results exist concerning the dopamine effect on the gross electrical activity of the retina [reflected in electroretinogram (ERG)] and the receptors involved in its action. This review summarized current knowledge about the types of the dopaminergic neurons and receptors in the retina as well as the effects of dopamine receptor agonists and antagonists on the light responses of photoreceptors, horizontal and bipolar cells in both nonmammalian and mammalian retina. Special focus of interest concerns their effects upon the diffuse ERG as a useful tool for assessment of the overall function of the distal retina. An attempt is made to reveal some differences between the dopamine actions upon the activity of the ON versus OFF channel in the distal retina. The author has included her own results demonstrating such differences.
Collapse
Affiliation(s)
- E Popova
- Department of Physiology, Medical Faculty, Medical University, 1431, Sofia, Bulgaria,
| |
Collapse
|
5
|
Zhang AJ, Jacoby R, Wu SM. Light- and dopamine-regulated receptive field plasticity in primate horizontal cells. J Comp Neurol 2011; 519:2125-34. [PMID: 21452210 DOI: 10.1002/cne.22604] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Center-surround antagonistic receptive fields (CSARFs) are building blocks for spatial vision and contrast perception. Retinal horizontal cells (HCs) are the first lateral elements along the visual pathway, and are thought to contribute to receptive field surrounds of higher order neurons. Primate HC receptive fields have not been found to change with light, and dopaminergic modulation has not been investigated. Recording intracellularly from HCs in dark-adapted macaque retina, we found that H1-HCs had large receptive fields (λ = 1,158 ± 137 μm) that were reduced by background light (-45%), gap junction closure (-53%), and D1 dopamine receptor activation (-48%). Tracer coupling was modulated in a correlative manner, suggesting that coupling resistance plays a dominant role in receptive field formation under low light conditions. The D1 antagonist SCH23390 increased the size of receptive fields (+13%), suggesting tonic dopamine release in the dark. Because light elevates dopamine release in primate retina, our results support a dopaminergic role in post-receptoral light adaptation by decreasing HC receptive field diameters, which influences the center-surround receptive field organization of higher-order neurons and thereby spatial contrast sensitivity.
Collapse
Affiliation(s)
- Ai-Jun Zhang
- Cullen Eye Institute, Baylor College of Medicine, Houston, Texas 77030, USA
| | | | | |
Collapse
|
6
|
Kim JS, Bailey MJ, Weller JL, Sugden D, Rath MF, Møller M, Klein DC. Thyroid hormone and adrenergic signaling interact to control pineal expression of the dopamine receptor D4 gene (Drd4). Mol Cell Endocrinol 2010; 314:128-35. [PMID: 19482058 PMCID: PMC2783391 DOI: 10.1016/j.mce.2009.05.013] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/30/2009] [Revised: 05/18/2009] [Accepted: 05/21/2009] [Indexed: 11/28/2022]
Abstract
Dopamine plays diverse and important roles in vertebrate biology, impacting behavior and physiology through actions mediated by specific G-protein-coupled receptors, one of which is the dopamine receptor D4 (Drd4). Here we present studies on the >100-fold daily rhythm in rat pineal Drd4 expression. Our studies indicate that Drd4 is the dominant dopamine receptor gene expressed in the pineal gland. The gene is expressed in pinealocytes at levels which are approximately 100-fold greater than in other tissues, except the retina, in which transcript levels are similar. Pineal Drd4 expression is circadian in nature and under photoneural control. Whereas most rhythmically expressed genes in the pineal are controlled by adrenergic/cAMP signaling, Drd4 expression also requires thyroid hormone. This advance raises the questions of whether Drd4 expression is regulated by this mechanism in other systems and whether thyroid hormone controls expression of other genes in the pineal gland.
Collapse
Affiliation(s)
- Jong-So Kim
- Section on Neuroendocrinology, Program on Developmental Endocrinology and Genetics, National Institutes of Health, Bethesda, MD 20892, USA
- Department of Life Science, POSTECH, Pohang 790-784, Korea
| | - Michael J. Bailey
- Section on Neuroendocrinology, Program on Developmental Endocrinology and Genetics, National Institutes of Health, Bethesda, MD 20892, USA
- Department of Poultry Science, Texas A&M University, College Station, TX 77843
| | - Joan L. Weller
- Section on Neuroendocrinology, Program on Developmental Endocrinology and Genetics, National Institutes of Health, Bethesda, MD 20892, USA
| | - David Sugden
- Division of Reproduction and Endocrinology, School of Biomedical & Health Sciences, King's College London, London SE1 1UL, United Kingdom
| | - Martin F. Rath
- Department of Neuroscience and Pharmacology, University of Copenhagen, Panum Institute 24.3, Blegdamsvej 3, DK-2200 Copenhagen, Denmark
| | - Morten Møller
- Department of Neuroscience and Pharmacology, University of Copenhagen, Panum Institute 24.3, Blegdamsvej 3, DK-2200 Copenhagen, Denmark
| | - David C. Klein
- Section on Neuroendocrinology, Program on Developmental Endocrinology and Genetics, National Institutes of Health, Bethesda, MD 20892, USA
- To whom correspondence should be addressed at, Building 49, Room 6A82, National Institutes of Health, Bethesda, MD 20892, USA, Tel.: 301-496-6915; Fax: 301-480-3526;
| |
Collapse
|
7
|
Shirani A, St. Louis EK. Illuminating rationale and uses for light therapy. J Clin Sleep Med 2009; 5:155-163. [PMID: 19968050 PMCID: PMC2670336] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
Light therapy is increasingly applied in a variety of sleep medicine and psychiatric conditions including circadian rhythm sleep disorders, seasonal affective disorder, and dementia. This article reviews the neural underpinnings of circadian neurobiology crucial for understanding the influence of light therapy on brain function, common mood and sleep disorders in which light therapy may be effectively used, and applications of light therapy in clinical practice.
Collapse
Affiliation(s)
- Afshin Shirani
- Department of Neurology, University of Iowa Hospitals and Clinics, and University of Iowa Carver College of Medicine, Iowa City, IA
| | - Erik K. St. Louis
- Center for Sleep Medicine, Mayo Clinic and Foundation, Rochester, MN
| |
Collapse
|